BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19001432)

  • 1. Dithiolethiones for cancer chemoprevention: where do we stand?
    Zhang Y; Munday R
    Mol Cancer Ther; 2008 Nov; 7(11):3470-9. PubMed ID: 19001432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for thiol-dependent production of oxygen radicals by 4-methyl-5-pyrazinyl-3H-1,2-dithiole-3-thione (oltipraz) and 3H-1,2-dithiole-3-thione: possible relevance to the anticarcinogenic properties of 1,2-dithiole-3-thiones.
    Kim W; Gates KS
    Chem Res Toxicol; 1997 Mar; 10(3):296-301. PubMed ID: 9084909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships in the induction of Phase II enzymes by derivatives of 3H-1,2-dithiole-3-thione in rats.
    Munday R; Zhang Y; Munday CM; Li J
    Chem Biol Interact; 2006 Mar; 160(2):115-22. PubMed ID: 16458871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones.
    Kwak MK; Egner PA; Dolan PM; Ramos-Gomez M; Groopman JD; Itoh K; Yamamoto M; Kensler TW
    Mutat Res; 2001 Sep; 480-481():305-15. PubMed ID: 11506823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins.
    Kensler TW; Curphey TJ; Maxiutenko Y; Roebuck BD
    Drug Metabol Drug Interact; 2000; 17(1-4):3-22. PubMed ID: 11201301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of chemoprotection by oltipraz.
    Kensler T; Styczynski P; Groopman J; Helzlsouer K; Curphey T; Maxuitenko Y; Roebuck BD
    J Cell Biochem Suppl; 1992; 16I():167-72. PubMed ID: 1305682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.
    Roebuck BD; Curphey TJ; Li Y; Baumgartner KJ; Bodreddigari S; Yan J; Gange SJ; Kensler TW; Sutter TR
    Carcinogenesis; 2003 Dec; 24(12):1919-28. PubMed ID: 14555609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dithiolethiones: a privileged pharmacophore for anticancer therapy and chemoprevention.
    Ansari MI; Khan MM; Saquib M; Khatoon S; Hussain MK
    Future Med Chem; 2018 May; 10(10):1241-1260. PubMed ID: 29749746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oltipraz: a laboratory and clinical review.
    Benson AB
    J Cell Biochem Suppl; 1993; 17F():278-91. PubMed ID: 8412206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione.
    Kensler TW; Groopman JD; Eaton DL; Curphey TJ; Roebuck BD
    Carcinogenesis; 1992 Jan; 13(1):95-100. PubMed ID: 1346373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic constraints for the thiolysis of 4-methyl-5-(pyrazin-2-yl)-1,2-dithiole-3-thione (oltipraz) and related dithiole-3-thiones in aqueous solution.
    Carey KA; Kensler TW; Fishbein JC
    Chem Res Toxicol; 2001 Aug; 14(8):939-45. PubMed ID: 11511166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,2-dithiole-3-thione and its structural analogue oltipraz are potent inhibitors of dibenz.
    Smith WA; Arif JM; Gupta RC
    Int J Cancer; 2001 Jan; 91(1):132-6. PubMed ID: 11149412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation, and structure-activity relationships of dithiolethiones as inducers of cytoprotective phase 2 enzymes.
    Munday R; Zhang Y; Paonessa JD; Munday CM; Wilkins AL; Babu J
    J Med Chem; 2010 Jun; 53(12):4761-7. PubMed ID: 20481594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of protein tyrosine phosphatases by oltipraz and other cancer chemopreventive 1,2-dithiole-3-thiones.
    Bhattacharyya S; Zhou H; Seiner DR; Gates KS
    Bioorg Med Chem; 2010 Aug; 18(16):5945-9. PubMed ID: 20655236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention by inducers of carcinogen detoxication enzymes.
    Kensler TW
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):965-70. PubMed ID: 9255588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of dithiolethiones with better chemopreventive properties than oltipraz.
    Maxuitenko YY; Libby AH; Joyner HH; Curphey TJ; MacMillan DL; Kensler TW; Roebuck BD
    Carcinogenesis; 1998 Sep; 19(9):1609-15. PubMed ID: 9771932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB activation by the chemopreventive dithiolethione oltipraz is exerted through stimulation of MEKK3 signaling.
    Nho CW; O'Dwyer PJ
    J Biol Chem; 2004 Jun; 279(25):26019-27. PubMed ID: 15047705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer chemoprotection by oltipraz: experimental and clinical considerations.
    Helzlsouer KJ; Kensler TW
    Prev Med; 1993 Sep; 22(5):783-95. PubMed ID: 8234218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione.
    Kwak MK; Itoh K; Yamamoto M; Sutter TR; Kensler TW
    Mol Med; 2001 Feb; 7(2):135-45. PubMed ID: 11471548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical genomics of cancer chemopreventive dithiolethiones.
    Tran QT; Xu L; Phan V; Goodwin SB; Rahman M; Jin VX; Sutter CH; Roebuck BD; Kensler TW; George EO; Sutter TR
    Carcinogenesis; 2009 Mar; 30(3):480-6. PubMed ID: 19126641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.